| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.007 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.007 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.097 | 0.007 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.086 | 0.008 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.096 | 0.008 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.008 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.008 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.009 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.009 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.009 |